These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8316763)

  • 1. Cell-mediated immune responses in renal transplant recipients treated with cyclosporin and prednisolone with or without azathioprine.
    Wramner L; Mjörnstedt L; Rydberg L; Olausson M
    Scand J Immunol; 1993 Jun; 37(6):656-60. PubMed ID: 8316763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients.
    Wramner L; Olausson M; Söderström T; Lindholm L; Rydberg L; Brynger H
    Transplantation; 1987 Sep; 44(3):390-5. PubMed ID: 2957836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
    Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG
    Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized multicenter trial of cyclosporin and prednisolone versus cyclosporin, azathioprine, and prednisolone following primary living donor renal transplantation.
    Lindholm A; Albrechtsen D; Flatmark A; Tufveson G; Persson NH; Frödin L; Groth CG
    Transpl Int; 1994 May; 7(3):207-15. PubMed ID: 8060471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of cyclosporine to azathroprine in renal transplant recipients.
    Bassiri A; Amiranssari B; Gol S
    Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful conversion from cyclosporine to azathioprine in elective renal transplant recipients.
    Chuang FR; Hsieh H; Hsu KT; Chien YS; Chung HM
    Transplant Proc; 1998 Nov; 30(7):3094-6. PubMed ID: 9838365
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.
    Gerrits JH; van de Wetering J; Weimar W; van Besouw NM
    Transplantation; 2009 Mar; 87(6):907-14. PubMed ID: 19300195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine.
    Oka K; Shimodaira H; Hirano T; Sakurai E; Tamaki T; Kozaki M
    Transplantation; 1993 Sep; 56(3):603-9. PubMed ID: 8212155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
    Chocair PR; Duley JA; Cameron JS; Arap S; Ianhez L; Sabbaga E; Simmonds HA
    Adv Exp Med Biol; 1994; 370():205-8. PubMed ID: 7660891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cell-mediated lympholysis in kidney transplantation].
    Samaniego MC; Martín RS; Rodríguez SG; Aguirre C
    Medicina (B Aires); 1990; 50(6):499-504. PubMed ID: 2151824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in cyclosporin and azathioprine treated renal transplant patients.
    McGrath LT; Treacy R; McClean E; Brown JH
    Clin Chim Acta; 1997 Aug; 264(1):1-12. PubMed ID: 9267698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound effect of the allogenic T-cell response to donor and third-party lymphocytes after cyclosporine withdrawal in renal transplant recipients.
    Creemers P; Pascoe MD; Pontin AR; Kahn D
    Transpl Immunol; 1998 Dec; 6(4):261-4. PubMed ID: 10342740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif AK; Fouda MA
    Am J Nephrol; 1993; 13(6):437-41. PubMed ID: 8141177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.